HomeGeneticsConditionInfantile neuroaxonal dystrophy
Back to Condition
Infantile neuroaxonal dystrophy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Infantile neuroaxonal dystrophy

Infantile neuroaxonal dystrophy is a rare, progressive disorder that primarily affects the nervous system, leading to developmental regression and movement difficulties.

Overview

Infantile neuroaxonal dystrophy is a disorder that primarily affects the nervous system. While individuals typically appear healthy at birth, they begin to experience delays in motor and intellectual skills between 6 and 18 months of age, eventually losing previously acquired skills (developmental regression).

Symptoms

  • Movement: Muscles are initially weak and "floppy" (hypotonic) before becoming very stiff (spastic). Eventually, children lose the ability to move independently.
  • Feeding and breathing: Muscle weakness leads to feeding difficulties and breathing problems, which can cause frequent infections like pneumonia.
  • Vision and hearing: Rapid, involuntary eye movements (nystagmus), eyes that do not look in the same direction (strabismus), and vision loss due to optic nerve atrophy. Hearing loss may also occur.
  • Cognitive: Progressive deterioration of cognitive functions (dementia) and loss of awareness of surroundings. Seizures occur in some children.

Causes

Most cases are caused by mutations in the PLA2G6 gene, which provides instructions for an enzyme called A2 phospholipase. This enzyme is involved in breaking down fats called phospholipids, which are crucial for maintaining cell membranes. Impaired function of this enzyme may disrupt cell membrane maintenance and lead to the development of swellings called spheroid bodies in the axons of nerve cells. The exact link between these cellular changes and the clinical symptoms remains under study.

Inheritance

This condition is inherited in an autosomal recessive pattern. Both copies of the gene in each cell must have mutations to cause the disorder. Parents of an affected individual typically carry one copy of the mutated gene without showing symptoms.

Frequently Asked Questions

Regression typically appears between 6 and 18 months, after an initial period of normal development. Watch for loss of previously achieved milestones such as sitting, crawling, or babbling. A sudden decline in motor skills or speech should prompt a neurologic evaluation.
Use thickened feeds or specialized formulas to prevent aspiration. Position the child upright during and after feeds, and consider a speech‑language pathologist for swallowing therapy. For respiratory protection, schedule regular chest physiotherapy, monitor for cough or wheezing, and keep vaccinations (influenza, pneumococcal) up to date.
Research is exploring gene‑replacement therapy for PLA2G6 mutations and neuroprotective agents targeting axonal degeneration. Families can discuss trial eligibility with a specialized neurologist, and genetic counseling can provide information on ongoing studies and potential participation.===
Begin evaluations as soon as nystagmus or hearing loss is suspected. Early referral to a pediatric ophthalmologist and audiologist can lead to interventions such as vision therapy, prism glasses, hearing aids, or cochlear implants. Consistent use of these aids, combined with occupational therapy, can improve functional outcomes.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA